Real-World Evidence for Oncology Patients With Rare <i>NTRK</i> Gene Fusions: Final Results From the German Multicenter Patient Cohort Study REALTRK. [PDF]
JCO Precis OncolPotthoff K +12 more
europepmc +1 more source
Integrative transcriptomic and experimental analyses prioritize TPT1 as a PANoptosis-associated candidate molecular marker in sarcopenia. [PDF]
Front Cell Dev BiolDong S +11 more
europepmc +1 more source
NTRK1-rearranged histiocytosis:clinicopathologic and molecular features
Non-Langerhans cell histiocytoses are a diverse group of histiocytic diseases. Different entities are defined based on clinical, histopathologic, and/or molecular characteristics. This study aimed to define NTRK-rearranged histiocytosis. Through international collaboration, we investigated 50 cases of histiocytosis with pan-tropomyosin receptor kinase (
Fragneau,Rivers +36 more
openaire +1 more source
Cancer of Unknown Primary Most Suggestive of Colorectal Origin With Microsatellite Instability-high Status and High Tumor Mutation Burden Including NTRK Fusion. [PDF]
Cancer Diagn PrognSato H +8 more
europepmc +1 more source
Identification and Functional Characterization of Novel and Recurrent NTRK1 Variants in Chinese Families With Congenital Insensitivity to Pain With Anhidrosis: A Combined Clinical, Genetic, and Functional Study. [PDF]
Eur J NeurolRen Y +9 more
europepmc +1 more source